Patents by Inventor Hsiou-Yu Ding

Hsiou-Yu Ding has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170198318
    Abstract: A method of manufacturing methoxy-isoflavones by biotransformation and a use thereof are revealed herein. The method comprises the steps of synthesizing a nucleic acid sequence including a SpOMT2884 gene ofStreptomyces peucetius; cloning the nucleic acid sequence into an expression vector to form a cyclic recombinant plasmid; transforming the cyclic recombinant plasmid into a microbial expression system (Escherichia coli); and incubating the microbial expression system in a medium containing 8-hydroxydaidzeins therein for generating methoxy-isoflavones.
    Type: Application
    Filed: December 23, 2016
    Publication date: July 13, 2017
    Inventors: TE-SHENG CHANG, YA-TING TSAI, HSIOU-YU DING, CHIEN-MIN CHIANG
  • Patent number: 9056067
    Abstract: A pharmaceutical composition is used to enhance immunity of the human body. The composition contains potent components of lanostane compounds. A method is devised to obtain an extract from metabolite, sclerotium, or fermentation product of Poria cocas (Schw) Wolf. The extract contains 5-60% of the lanostane compounds by weight of the extract. The extract is devoid of secolanostane capable of inhibiting immunity development.
    Type: Grant
    Filed: November 1, 2013
    Date of Patent: June 16, 2015
    Assignee: Sinphar Pharmaceutical Co., Ltd.
    Inventors: Hang-Chin Lin, Jerming Tseng, Hsiou-Yu Ding, Wen-Liang Chang, Chien-Lian Chao, Hsin-Wen Huang
  • Publication number: 20140065174
    Abstract: A pharmaceutical composition is used to enhance immunity of the human body. The composition contains potent components of lanostane compounds. A method is devised to obtain an extract from metabolite, sclerotium, or fermentation product of Poria cocos (Schw) Wolf. The extract contains 5-60% of the lanostane compounds by weight of the extract. The extract is devoid of secolanostane capable of inhibiting immunity development.
    Type: Application
    Filed: November 1, 2013
    Publication date: March 6, 2014
    Applicant: Sinphar Pharmaceutical Co., Ltd.
    Inventors: Hang-Ching Lin, Jerming Tseng, Hsiou-Yu Ding, Wen-Liang Chang, Chien-Lian Chao, Hsin-Wen Huang
  • Publication number: 20120196816
    Abstract: The present application relates to a method for enhancing absorption of a nutrient in a subject in need thereof with an effective amount of an isolated astragaloside compound.
    Type: Application
    Filed: April 11, 2012
    Publication date: August 2, 2012
    Applicant: NuLiv Holding Inc.
    Inventors: Hang-Ching Lin, Wen-Liang Chang, Tsu-Chung Chang, Hsiou-Yu Ding, Tian Shung Wu
  • Publication number: 20120196817
    Abstract: The present application relates to a method for enhancing absorption of a nutrient in a subject in need thereof with an effective amount of an isolated astragaloside compound.
    Type: Application
    Filed: April 11, 2012
    Publication date: August 2, 2012
    Applicant: NuLiv Holding Inc.
    Inventors: Hang-Ching Lin, Wen-Liang Chang, Tsu-Chung Chang, Hsiou-Yu Ding, Tian Shung Wu
  • Patent number: 8197860
    Abstract: The present application relates to a method for enhancing absorption of a nutrient in a subject in need thereof with an effective amount of an isolated astragaloside compound.
    Type: Grant
    Filed: April 15, 2009
    Date of Patent: June 12, 2012
    Assignee: Nuliv Holding Inc.
    Inventors: Hang-Ching Lin, Wen-Liang Chang, Tsu-Chung Chang, Hsiou-Yu Ding, Tian Shung Wu
  • Publication number: 20100298283
    Abstract: A pharmaceutical composition is used to enhance immunity of the human body. The composition contains potent components of lanostane compounds. A method is devised to obtain an extract from metabolite, sclerotium, or fermentation product of Poria cocos (Schw) Wolf. The extract contains 5-60% of the lanostane compounds by weight of the extract. The extract is devoid of secolanostane capable of inhibiting immunity development.
    Type: Application
    Filed: July 19, 2010
    Publication date: November 25, 2010
    Applicant: Sinphar Pharmaceutical Co., Ltd.
    Inventors: Hang-Ching Lin, Jerming Tseng, Hsiou-Yu Ding, Wen-Liang Chang, Chien-Lian Chao, Hsin-Wen Huang
  • Patent number: 7714026
    Abstract: The present invention discloses a novel use of bakuchiol or an extract containing bakuchiol in preventing or treating a woman suffering osteoporosis. An embodiment of this novel use is a pharmaceutical composition containing bakuchiol or an extract containing bakuchiol, which can be in the dosage forms of topical use, oral administration, injection or sustained release. The present invention also discloses a novel use of bakuchiol or an extract containing bakuchiol in preventing or treating a woman suffering breast cancer.
    Type: Grant
    Filed: May 11, 2005
    Date of Patent: May 11, 2010
    Assignee: Sinphar Pharmaceutical Co., Ltd.
    Inventors: Hang-Ching Lin, Hsiou-Yu Ding, Wen-Liang Chang, Chien-Lian Chao, Hsin-Wen Huang, Chin-Liang Lin
  • Publication number: 20100099633
    Abstract: The present application relates to a method for enhancing absorption of a nutrient in a subject in need thereof with an effective amount of an isolated astragaloside compound.
    Type: Application
    Filed: April 15, 2009
    Publication date: April 22, 2010
    Applicant: NuLiv Holding Inc.
    Inventors: Hang-Ching Lin, Wen-Liang Chang, Tsu-Chung Chang, Hsiou-Yu Ding, Tian Shung Wu
  • Publication number: 20090181904
    Abstract: The present application relates to a method of regulating nutrient absorption in a subject in need thereof with an isolated ginsenoside compound.
    Type: Application
    Filed: December 29, 2008
    Publication date: July 16, 2009
    Applicant: NULIV HOLDING INC.
    Inventors: Hang-Ching Lin, Wen- Liang Chang, Tsu-Chung Chang, Hsiou-Yu Ding, Tian Shung Wu
  • Publication number: 20060292251
    Abstract: There is provided a method for enhancing the absorption of a nutrient in a subject, including administering to the subject an effective amount of a astragaloside compound purified from Astragalus membranaceus var. mongholicus for facilitating transportation of the nutrient across gut cells of the subject.
    Type: Application
    Filed: June 23, 2006
    Publication date: December 28, 2006
    Applicant: NULIV SCIENCE INC. - A TAIWAN, R.O.C. CORPORATION
    Inventors: Hang-Ching LIN, Wen-Liang CHANG, Tsu-Chung CHANG, Hsiou-Yu DING, Tian WU
  • Publication number: 20060293255
    Abstract: There is provided a method for regulating the absorption of a nutrient in a subject, including administering to the subject an effective amount of a ginsenoside compound purified from Panax notoginseng for modulating transportation of the nutrient across gut cells of the subject.
    Type: Application
    Filed: June 23, 2006
    Publication date: December 28, 2006
    Applicant: NULIV SCIENCE INC. - A TAIWAN, R.O.C. CORPORATION
    Inventors: Hang-Ching LIN, Wen-Liang CHANG, Tsu-Chung CHANG, Hsiou-Yu DING, Tian WU
  • Publication number: 20050256208
    Abstract: The present invention discloses a novel use of bakuchiol or an extract containing bakuchiol in preventing or treating a woman suffering breast cancer. An embodiment of this novel use is a pharmaceutical composition containing bakuchiol or an extract containing bakuchiol, which can be in the dosage forms of topical use, oral administration, injection or sustained release. The present invention also discloses a novel use of bakuchiol or an extract containing bakuchiol in preventing or treating a woman suffering osteoporosis.
    Type: Application
    Filed: May 11, 2005
    Publication date: November 17, 2005
    Applicant: Sinphar Pharmaceutical Co., Ltd.
    Inventors: Hang-Ching Lin, Hsiou-Yu Ding, Wen-Liang Chang, Chien-Lian Chao, Hsin-Wen Huang
  • Publication number: 20050256209
    Abstract: The present invention discloses a novel use of bakuchiol or an extract containing bakuchiol in preventing or treating a woman suffering osteoporosis. An embodiment of this novel use is a pharmaceutical composition containing bakuchiol or an extract containing bakuchiol, which can be in the dosage forms of topical use, oral administration, injection or sustained release. The present invention also discloses a novel use of bakuchiol or an extract containing bakuchiol in preventing or treating a woman suffering breast cancer.
    Type: Application
    Filed: May 11, 2005
    Publication date: November 17, 2005
    Applicant: Sinphar Pharmaceutical Co., Ltd.
    Inventors: Hang-Ching Lin, Hsiou-Yu Ding, Wen-Liang Chang, Chien-Liang Chao, Hsin-Wen Huang, Chin-Liang Lin
  • Publication number: 20040229852
    Abstract: A pharmaceutical composition is used to enhance immunity of human body. The composition contains potent components of lanostan compounds. A method is devised to obtain an extract from metabolit, sclerotium, or fermentation product of Poria cocos (Schw) Wolf. The extract contains 5-60% of the lanostane compounds by weight of the extract. The extract is devoid of secolanostane capable of inhibiting immunity development.
    Type: Application
    Filed: November 21, 2003
    Publication date: November 18, 2004
    Applicant: Sinphar Pharmaceutical Co., Ltd.
    Inventors: Hang-Ching Lin, Jerming Tseng, Hsiou-Yu Ding, Wen-Liang Chang, Chien-Lian Chao, Hsin-Wen Huang